Читать книгу Praxishandbuch Altersmedizin - Группа авторов - Страница 79

AEZQ German Agency for Quality in Medicine. (2009) Nationale VersorgungsLeitlinie Herzinsuffizienz (NVL Herzinsuffizienz). (http://www. versorgungsleitlinien.de/themen/herzinsuffizienz. Retrieved from http://www.versorgungsleitlinien.de/themen/herzinsuffizienz).

Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. (2012) Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC. Public Health 12: 201. (doi:1471-2458-12-201 [pii];10.1186/1471-2458-12-201 [doi]).

AGS (2012) Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J. Am. Geriatr. Soc 60(10): E1–E25.

Ahluwalia SC, Gross CP, Chaudhry SI, Leo-Summers L, Van Ness PH, Fried TR (2011) Change in comorbidity prevalence with advancing age among persons with heart failure. J. Gen. Intern. Med 26(10): 1145–1151.

Ahluwalia SC, Gross CP, Chaudhry SI, Ning YM, Leo-Summers L, Van Ness PH et al. (2012) Impact of comorbidity on mortality among older persons with advanced heart failure. J. Gen. Intern. Med 27(5): 513–519.

Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380(9836): 37–43.

Bourgeois FT, Orenstein L, Ballakur S, Mandl KD, Ioannidis JPA (2017) Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease. J Am Geriatr Soc, 65(11): 2354–2361. (doi:10.1111/jgs.14833).

Bower P (2014) Better management of multimorbidity: a critical look at the ›Ariadne principles‹. BMC Med 12: 222.

Bower P, Macdonald W, Harkness E, Gask L, Kendrick T, Valderas JM et al. (2011) Multimorbidity, service organization and clinical decision making in primary care: a qualitative study. Fam. Pract, 28(5): 579–587.

Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294(6): 716–724.

Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R et al. (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J. Am. Coll. Cardiol 42(7): 1226–1233.

Burgers JS, Voerman GE, Grol R, Faber MJ, Schneider EC (2010) Quality and coordination of care for patients with multiple conditions: results from an international survey of patient experience. Eval. Health Prof 33(3): 343–364.

Carey EC, Covinsky KE, Lui LY, Eng C, Sands LP, Walter LC (2008) Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 56(1): 68–75. (doi:10.1111/j.1532-5415.2007.01496.x).

Carmona M, Garcia-Olmos LM, Alberquilla A, Munoz A, Garcia-Sagredo P, Somolinos R et al. (2011) Heart failure in the family practice: a study of the prevalence and co-morbidity. Fam. Pract 28(2): 128–133.

Cassell A, Edwards D, Harshfield A, Rhodes K, Brimicombe J, Payne R, et al. (2018) The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 68(669): e245–e251. (doi:10.3399/bjgp18X695465).

Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch. Intern. Med 150(4): 841–845.

Committee on Quality of Health Care in America, Medicine Io. (2001) Crossing the quality chasm: a new health system for the 21st century. (2 ed.). Washington,D.C.: National Academy Press.

Dumbreck S, Flynn A, Nairn M, Wilson M, Treweek S, Mercer SW et al. (2015) Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 350: h949.

Feinstein AR (1970) The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases 23(7): 455–468.

Fortin M, Contant E, Savard C, Hudon C, Poitras ME, Almirall J (2011) Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity. BMC. Fam. Pract 12: 74.

Fried T, McGraw S, Agostini J, Tinette M (2008) Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. JAGS 56: 1839–1844.

Fried TR, McGraw S, Agostini JV, Tinetti ME (2008) Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J. Am. Geriatr. Soc 56(10): 1839–1844. (doi:JGS1923 [pii];10.1111/j.1532-5415.2008.01923.x [doi]).

Fried TR, Tinetti M, Agostini J, Iannone L, Towle V (2011a) Health outcome prioritization to elicit preferences of older persons with multiple health conditions. Patient. Educ. Couns, 83(2): 278–282.

Fried TR, Tinetti ME, Iannone L (2011b) Primary care clinicians’ experiences with treatment decision making for older persons with multiple conditions. Arch. Intern. Med 171(1): 75–80. (doi:archinternmed.2010.318 [pii];10.1001/archinternmed.2010.318 [doi]).

Fried TR, Tinetti ME, Iannone L, O'Leary JR, Towle V, Van Ness PH (2011) Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch. Intern. Med 171(20): 1854–1856. (doi:archinternmed.2011.424 [pii];10.1001/archinternmed.2011.424 [doi]).

Gensichen J, Muth C, Butzlaff M, Rosemann T, Raspe H, de Cornejo GM et al. (2006) The future is chronic: German primary care and the Chronic Care Model – The comprehensive principles in the proactive treatment of the chronically ill]. Z. Arztl. Fortbild. Qualitatssich 100(5): 365–374.

Gorenoi V, Schönermark MP, Hagen A (2007) Maßnahmen zur Verbesserung der Compliance bzw. Adherence in der Arzneimitteltherapie mit Hinblick auf den Therapieerfolg (Vol. Band 65). Köln.

Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC et al. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289(9): 1107–1116.

Heider D, Matschinger H, Muller H, Saum KU, Quinzler R, Haefeli WE et al. (2014) Health care costs in the elderly in Germany: an analysis applying Andersen's behavioral model of health care utilization. BMC Health Serv Res 14: 71. (doi:10.1186/1472-6963-14-71).

Held FP, Blyth F, Gnjidic D, Hirani V, Naganathan V, Waite LM et al. (2016) Association Rules Analysis of Comorbidity and Multimorbidity: The Concord Health and Aging in Men Project. J Gerontol A Biol Sci Med Sci 71(5): 625–631. (doi:10.1093/gerona/glv181).

Hessel A, Gunzelmann T, Geyer M, Brahler E (2000) Utilization of medical services and medication intake of patients over 60 in Germany – health related, social structure related, socio-demographic and subjective factors. Z. Gerontol. Geriatr 33(4): 289–299.

Holmes HM (2012) Meeting of the American Geriatrics Society, Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians. Implementing the Principles in Your Practice.

Horne R, Weinman J, Barber N, Elliott R, Morgan M, Cribb A et al. (2005) Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). NCCSDO. (http://www.netscc.ac.uk/hsdr/files/project/SDO_FR_08-1412-076_V01.pdf, Zugriff am 14.07.2020).

Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS (2014) Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS ONE 9(1): e83783. (doi:10.1371/journal.pone.0083783).

Jennings L (2015) Management of older adults with multiple chronic conditions. (Retrieved from Project ECHO L.A.TM website: http://www.projectechola.org/wp-content/uploads/2015/07/Management-of-older-adults-with-MCC-7.7.15.pdf, Zugriff am 14.07.2020).

Jobst D, Mücke M (2018) Knieschmerz bei Arthrosezeichen. DEGAM S1-Handlungsempfehlung. AWMF-Register-Nr. 053-050. (Retrieved from DEGAM-Leitlinien website: https://www.degam.de/degam-leitlinien-379.html, Zugriff am 14.07.2020).

Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E et al. (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur. Heart J 26(16): 1653–1659.

Laux G, Kuehlein T, Rosemann T, Szecsenyi J (2008) Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. BMC. Health Serv. Res 8: 14.

Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC (2011) Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS. One 6(10): e25987.

Luijks HD, Loeffen MJ, Lagro-Janssen AL, van Weel C, Lucassen PL, Schermer TR (2012) GPs’ considerations in multimorbidity management: a qualitative study. Br. J. Gen. Pract 62(600): 503–510.

Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF et al. (2003) Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am. Heart J 146(2): 250–257.

May C, Montori VM, Mair FS (2009) We need minimally disruptive medicine. BMJ 339: b2803.

Muth C, Blom JW, Smith SM, Johnell K, Gonzalez-Gonzalez AI, Nguyen TS et al. (2018) Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med. (doi:10.1111/joim.12842).

Muth C, Kirchner H, van den Akker M, Scherer M, Glasziou PP (2014) Current guidelines poorly address multimorbidity: pilot of the interaction matrix method. J Clin Epidemiol 67: 1242–1250.

Muth C, van den Akker M, Blom JW, Mallen CD, Rochon J, Schellevis FG et al. (2014) The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med 12: 223.

NICE National Institute for Health and Clinical Excellence. (2016) Multimorbidity: clinical assessment and management; NICE guideline [NG56]. National Institute for Health and Clinical Excellence. (https://www.nice.org.uk/guidance/ng56/evidence/full-guideline-2615543103, Zugriff am 14.07.2020).

Nicholson K, Makovski TT, Griffith LE, Raina P, Stranges S, van den Akker M (2018) Multimorbidity and comorbidity revisited: Refining the concepts for international health research. J Clin Epidemiol. (doi:10.1016/j.jclinepi.2018.09.008).

Nobili A, Marengoni A, Tettamanti M, Salerno F, Pasina L, Franchi C et al. (2011) Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur. J. Intern. Med, 22(6): 597–602. (doi:S0953-6205(11)00213-5 [pii];10.1016/j.ejim.2011.08.029 [doi]).

Nunes BP, Flores TR, Mielke GI, Thume E, Facchini LA (2016) Multimorbidity and mortality in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr 67: 130–138. (doi:10.1016/j.archger.2016.07.008).

Oscanoa TJ, Lizaraso F, Carvajal A (2017) Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 73(6): 759–770. (doi:10.1007/s00228-017-2225-3).

Palladino R, Tayu Lee J, Ashworth M, Triassi M, Millett C (2016) Associations between multimorbidity, healthcare utilisation and health status: evidence from 16 European countries. Age Ageing 45(3): 431–435. (doi:10.1093/ageing/afw044).

Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF (2012) Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann. Intern. Med 157(4): 263–275.

Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR (2016) Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool. Clin Interv Aging 11: 497–505. (doi:10.2147/cia.S99097).

Pellegrin KL, Lee E, Uyeno R, Ayson C, Goo R (2017) Potentially preventable medication-related hospitalizations: A clinical pharmacist approach to assessment, categorization, and quality improvement. J Am Pharm Assoc 57(6): 711–716. (doi:10.1016/j.japh.2017.06.019).

Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456): 15–19.

Poblador-Plou B, van den AM, Vos R, Calderon-Larranaga A, Metsemakers J, Prados-Torres A (2014) Similar multimorbidity patterns in primary care patients from two European regions: results of a factor analysis. PLoS ONE 9(6): e100375.

Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M (2014) Multimorbidity patterns: a systematic review. J. Clin. Epidemiol 67(3): 254–266.

Prados-Torres A, del Cura-Gonzalez I, Prados-Torres D, Lopez-Rodriguez JA, Leiva-Fernandez F, Calderon-Larranaga A et al. (2017) Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). Implementation Science 12(1): 54.

Puth MT, Weckbecker K, Schmid M, Munster E (2017) Prevalence of multimorbidity in Germany: impact of age and educational level in a cross-sectional study on 19,294 adults. BMC Public Health 17(1): 826. (doi:10.1186/s12889-017-4833-3).

Ryan A, Wallace E, O'Hara P, Smith SM (2015) Multimorbidity and functional decline in community-dwelling adults: a systematic review. Health Qual Life Outcomes 13: 168. (doi:10.1186/s12955-015-0355-9).

Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen (SVR) (2009) Koordination und Integration – Gesundheitsversorgung in einer Gesellschaft des längeren Lebens. (http://www.svr-gesundheit.de/. Retrieved from https://www.svr-gesundheit.de/index.php?id=14, Zugriff am 28.07.2020)

Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA (2011) Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br. J. Gen. Pract 61(582): e12–e21.

Schaeffer D, Müller-Mundt G, Haslbeck J (2007) Bewältigung komplexer Medikamentenregime bei chronischen Erkrankungen – Herausforderungen aus Sicht der Gesundheitsprofessionen. In Veröffentlichungsreihe des Instituts für Pflegewissenschaft an der UniversitätBielefeld (IPW), P07-134. (Reprinted from: Not in File).

Schafer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A et al. (2012) The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study. BMC. Health Serv. Res 12: 89. (doi:1472-6963-12-89 [pii];10.1186/1472-6963-12-89 [doi]).

Schmiedl S, Rottenkolber M, Szymanski J, Drewelow B, Siegmund W, Hippius M et al. (2018) Preventable ADRs leading to hospitalization – results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients. Expert Opin Drug Saf 17(2): 125–137. (doi:10.1080/14740338.2018.1415322).

Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin. Pharmacol, 58(4) 285-291.

Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM et al. (2001) Validity of the agency for healthcare research and quality clinical practice guidelines. How quickly do guidelines become outdated? JAMA: the journal of the American Medical Association, 286(12): 1461–1467.

Sinnige J, Korevaar JC, Westert GP, Spreeuwenberg P, Schellevis FG, Braspenning JC (2015) Multimorbidity patterns in a primary care population aged 55 years and over. Fam Pract 32(5): 505–513. (doi:10.1093/fampra/cmv037).

Sinnott C, McHugh S, Browne J, Bradley C (2013) GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 3(9): e003610.

St Sauver JL, Boyd CM, Grossardt BR, Bobo WV, Finney Rutten LJ, Roger VL et al. (2015) Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open 5(2): e006413. (doi:10.1136/bmjopen-2014-006413).

Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, Weiner JP (2003) Comorbidity: implications for the importance of primary care in ›case‹ management. Ann Fam Med 1(1): 8–14.

Starfield BH, Simborg DW, Horn SD, Yourtee SA (1976) Continuity and coordination in primary care: their achievement and utility. Med. Care 14(7): 625–636.

Straubhaar B, Krahenbuhl S, Schlienger RG (2006) The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 29(1): 79–90.

Sum G, Hone T, Atun R, Millett C, Suhrcke M, Mahal A et al. (2018) Multimorbidity and out-of-pocket expenditure on medicines: a systematic review. BMJ Glob Health 3(1): e000505. (doi:10.1136/bmjgh-2017-000505).

Tacken MA, Opstelten W, Vossen I, Smeele IJ, Calsbeek H, Jacobs JE et al. (2011) Increased multimorbidity in patients in general practice in the period 2003-2009. Ned. Tijdschr. Geneeskd 155(26): A3109.

Tetzlaff J, Muschik D, Epping J, Eberhard S, Geyer S (2017) Expansion or compression of multimorbidity? 10-year development of life years spent in multimorbidity based on health insurance claims data of Lower Saxony, Germany. Int J Public Health 62(6): 679–686. (doi:10.1007/s00038-017-0962-9).

Thomas L, Cullum N, McColl E, Rousseau N, Soutter J, Steen N (2000) Guidelines in professions allied to medicine. Cochrane. Database. Syst. Rev(2): CD000349.

Tinetti ME, Bogardus ST, Jr., Agostini JV (2004) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N. Engl. J. Med 351(27): 2870–2874.

Tinetti ME, McAvay G, Trentalange M, Cohen AB, Allore HG (2015) Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ 351: h4984.

Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7(4): 357–363.

van den Akker M, Buntinx F, Knottnerus J (1996) Comorbidity or multimorbidity: what's in a name. A review of literature. Eur J Gen Pract 2: 65–70.

van den Akker M, Buntinx F, Metsemakers JF, Knottnerus JA (2000) Marginal impact of psychosocial factors on multimorbidity: results of an explorative nested case-control study. Soc. Sci. Med, 50(11): 1679–1693.

van den Akker M, Buntinx F, Metsemakers JF, van der AM, Knottnerus JA (2001) Psychosocial patient characteristics and GP-registered chronic morbidity: a prospective study. J. Psychosom. Res 50(2): 95–102.

van Deudekom FJ, Postmus I, van der Ham DJ, Pothof AB, Broekhuizen K, Blauw GJ et al. (2017) External validity of randomized controlled trials in older adults, a systematic review. PLoS ONE 12(3): e0174053. (doi:10.1371/journal.pone.0174053).

van Oostrom SH, Gijsen R, Stirbu I, Korevaar JC, Schellevis FG, Picavet HS et al. (2016) Time Trends in Prevalence of Chronic Diseases and Multimorbidity Not Only due to Aging: Data from General Practices and Health Surveys. PLoS ONE 11(8): e0160264. (doi:10.1371/journal.pone.0160264).

van Oostrom SH, Picavet HS, van Gelder BM, Lemmens LC, Hoeymans N, Verheij RA et al. (2011) Multimorbidity and comorbidity in the Dutch population – data from general practices. Ned. Tijdschr. Geneeskd 155: A3193.

Van Spall HG, Toren A, Kiss A, Fowler RA (2007) Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297(11): 1233–1240.

Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M et al. (2014) Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS ONE 9(7): e102149.

Vitry AI, Zhang Y (2008) Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med. J. Aust 189(7): 360–365.

Wammes JJG, van der Wees PJ, Tanke MAC, Westert GP, Jeurissen PPT (2018) Systematic review of high-cost patients’ characteristics and healthcare utilisation. BMJ Open 8(9): e023113. (doi:10.1136/bmjopen-2018-023113).

Wimmer BC, Bell JS, Fastbom J, Wiese MD, Johnell K (2016) Medication Regimen Complexity and Number of Medications as Factors Associated With Unplanned Hospitalizations in Older People: A Population-based Cohort Study. J Gerontol A Biol Sci Med Sci 71(6): 831–837. (doi:10.1093/gerona/glv219).

Wong CY, Chaudhry SI, Desai MM, Krumholz HM (2011) Trends in comorbidity, disability, and polypharmacy in heart failure. Am. J. Med 124(2): 136–143.

Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318(7182): 527–530.

Zemedikun DT, Gray LJ, Khunti K, Davies MJ, Dhalwani NN (2018) Patterns of Multimorbidity in Middle-Aged and Older Adults: An Analysis of the UK Biobank Data. Mayo Clin Proc 93(7): 857–866. (doi:10.1016/j.mayocp.2018.02.012).